Michael Terrence Gibbs, General Counsel at T2 Biosystems, Inc. (TTOO), sold 3,005 shares at $3.36 ($10K) on 2019-02-11, disclosed to the SEC on 2019-02-12.
Scheduled sale ($10k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TTOO | BUY | 2022-04-11 | $5K | — | Filing → |
| TTOO | SELL | 2021-03-25 | $14K | — | Filing → |
| TTOO | SELL | 2021-02-23 | $15K | — | Filing → |